Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery
暂无分享,去创建一个
G. Stone | A. Kirtane | Z. Ali | J. Moses | M. Leon | G. Mintz | D. Cohen | L. Ratner | A. Maehara | O. Ben‐Yehuda | D. Karmpaliotis | J. Radhakrishnan | M. Hardy | S. Mohan | G. Dube | R. Crew | Hussein M. Rahim | Fotis Gkargkoulas | E. Flattery | O. Ben-Yehuda | D. Cohen
[1] Guo-li Sun,et al. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography. , 2019, Heart, lung & circulation.
[2] H. Gurm,et al. Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] Z. Ali,et al. Zero contrast retrograde chronic total occlusions percutaneous coronary intervention: a case series , 2018, European heart journal. Case reports.
[4] M. Mosseri,et al. Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures , 2018, Nephron.
[5] Z. Ali,et al. Zero‐contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[6] Sunil V. Rao,et al. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. , 2017, The American journal of cardiology.
[7] G. Stone,et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. , 2016, European heart journal.
[8] P. Thompson,et al. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System. , 2016, The Journal of invasive cardiology.
[9] U. Schoepf,et al. Contrast-Induced Nephropathy , 2015, Circulation.
[10] G. Stone,et al. Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials , 2015, Circulation. Cardiovascular interventions.
[11] E. Edelman,et al. Intravascular Ultrasound Guidance to Minimize the use of Iodine Contrast in Percutaneous Coronary Intervention: The MOZART Randomized Controlled Trial , 2014 .
[12] Somjot S. Brar,et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.
[13] B. Rangan,et al. A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention). , 2013, JACC. Cardiovascular interventions.
[14] H. Gurm,et al. Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions. , 2013, JACC. Cardiovascular interventions.
[15] L. Wallentin,et al. Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.
[16] Keshav R. Nayak,et al. A novel technique for ultra‐low contrast administration during angiography or intervention , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[17] R. Elosua,et al. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. , 2010, Archives of internal medicine.
[18] R. Mehran,et al. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.
[19] W. Gibler,et al. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. , 2006, The American journal of medicine.
[20] B. Hemmelgarn,et al. Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.
[21] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[22] Robert M Califf,et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.
[23] Michael E Matheny,et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.
[24] G. Stone,et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.
[25] H. K. Pedersen. Electrolyte addition to nonionic contrast media. Cardiac effects during experimental coronary arteriography. , 1996, Acta radiologica. Supplementum.